| J B Chemicals & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506943 |
NSE Symbol : JBCHEPHARM |
P/E(TTM) : 51.17 |
|
ISIN Demat : INE572A01036 |
Div & Yield% : 0.65 |
EPS(TTM) : 36.83 |
|
Book Value(₹) : 185.83 |
Market Cap(₹Cr) : 29,269.00 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 3,298.64 | 2,884.16 | 2,189.88 | 1,892.00 | 1,640.74 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 3,298.64 | 2,884.16 | 2,189.88 | 1,892.00 | 1,640.74 |
| Other Income | 34.67 | 8.65 | 38.61 | 115.92 | 47.13 |
| Stock Adjustments | 49.22 | 27.48 | 25.57 | 15.70 | -2.53 |
| Total Income | 3,382.53 | 2,920.29 | 2,254.06 | 2,023.62 | 1,685.34 |
| EXPENDITURE : | |||||
| Raw Materials | 1,158.29 | 1,064.21 | 769.27 | 641.46 | 566.61 |
| Power and Fuel Cost | 87.95 | 91.44 | 71.37 | 62.60 | 61.54 |
| Other Manufacturing Expenses | 120.93 | 106.13 | 97.36 | 84.69 | 77.06 |
| Selling and Administration Expenses | 446.93 | 394.90 | 305.91 | 204.68 | 205.02 |
| Miscellaneous Expenses | 88.96 | 90.33 | 63.58 | 55.96 | 73.75 |
| Employee Benefit Expenses | 565.38 | 499.95 | 399.06 | 305.98 | 293.78 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 914.09 | 673.34 | 547.52 | 668.25 | 407.59 |
| Interest | 40.52 | 34.31 | 4.95 | 7.19 | 2.94 |
| Gross Profit | 873.57 | 639.03 | 542.57 | 661.06 | 404.65 |
| Depreciation | 135.24 | 111.99 | 71.28 | 67.36 | 65.09 |
| Profit Before Tax | 738.33 | 527.04 | 471.29 | 593.70 | 339.56 |
| Current Tax | 145.49 | 83.35 | 122.50 | 137.50 | 82.02 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 49.49 | 54.80 | -12.21 | 9.12 | -10.60 |
| Reported Net Profit | 543.36 | 388.89 | 361.00 | 447.08 | 268.14 |
| Extraordinary Items | 11.70 | 2.92 | 27.75 | 46.97 | 12.62 |
| Adjusted Net Profit | 531.66 | 385.97 | 333.25 | 400.11 | 255.52 |
| Adjustment below Net Profit | -3.71 | 0.13 | 0.07 | -12.50 | -5.06 |
| Profit/Loss Balance carried down | 2,070.16 | 1,808.73 | 1,575.18 | 1,214.01 | 1,092.46 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 156.99 | 127.59 | 127.52 | 73.42 | 141.53 |
| P & L Balance carried down | 2,452.82 | 2,070.16 | 1,808.73 | 1,575.18 | 1,214.01 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 1,225.00 | 887.50 | 825.00 | 825.00 | 550.00 |
| Dividend Per Share(Rs) | 12.25 | 17.75 | 16.50 | 16.50 | 11.00 |
| Earnings Per Share-Unit Curr | 35.01 | 50.26 | 46.71 | 57.85 | 34.70 |
| Earnings Per Share(Adj)-Unit Curr | 35.01 | 25.13 | 23.36 | 28.93 | 17.35 |
| Book Value | 185.98 | 315.65 | 272.21 | 233.75 | 187.02 |
| Book Value(Adj)-Unit Curr | 185.98 | 157.83 | 136.11 | 116.88 | 93.51 |